Travere Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Travere Therapeutics's estimated annual revenue is currently $89.9M per year.(i)
  • Travere Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Travere Therapeutics has 580 Employees.(i)
  • Travere Therapeutics grew their employee count by -10% last year.

Travere Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Sr. VP, Regulatory Affairs and QualityReveal Email/Phone
3
Chief IP Counsel - ContractReveal Email/Phone
4
VP, Research and Nonclinical DevelopmentReveal Email/Phone
5
VP Pharmacovigilance & Renal Clinical DevelopmentReveal Email/Phone
6
VP, Information TechnologyReveal Email/Phone
7
VP, Head Corporate CommunicationsReveal Email/Phone
8
SVP, General Counsel & SecretaryReveal Email/Phone
9
VP Regulatory AffairsReveal Email/Phone
10
VP, Associate General CounselReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Travere Therapeutics?

At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife

keywords:N/A

N/A

Total Funding

580

Number of Employees

$89.9M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Travere Therapeutics News

2022-04-20 - Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected to Earn ...

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) – Investment analysts at Jefferies Financial Group issued their Q2 2022 earnings per...

2022-04-19 - Is Travere Therapeutics Inc (TVTX) Stock a Smart Value Tuesday?

Travere Therapeutics Inc gets a 82 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors. Overall Score - 72. TVTX has an...

2022-04-17 - Where Does Travere Therapeutics Inc (TVTX) Stock Fall in the Biotechnology Field After It Is Down -4.09% This Week?

The 61 rating InvestorsObserver gives to Travere Therapeutics Inc (TVTX) stock puts it near the top of the Biotechnology industry.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$200.4M5835%N/A
#2
$131.2M583N/AN/A
#3
$153.6M5858%N/A
#4
$147.3M587-20%N/A
#5
$187.5M58827%N/A